Eisai (OTCMKTS:ESALY) vs. LONMIN PLC/S (OTCMKTS:LNMIY) Head-To-Head Comparison

Eisai (OTCMKTS:ESALY) and LONMIN PLC/S (OTCMKTS:LNMIY) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their institutional ownership, valuation, analyst recommendations, profitability, risk, dividends and earnings.

Valuation and Earnings

This table compares Eisai and LONMIN PLC/S’s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Eisai	$6.74 billion	2.62	$426.79 million	$0.87	70.70
LONMIN PLC/S	$1.35 billion	0.18	$42.00 million	N/A	N/A

Eisai has higher revenue and earnings than LONMIN PLC/S.

Volatility and Risk

Eisai has a beta of 0.31, indicating that its share price is 69% less volatile than the S&P 500. Comparatively, LONMIN PLC/S has a beta of 2.75, indicating that its share price is 175% more volatile than the S&P 500.

Analyst Recommendations

This is a summary of current ratings and recommmendations for Eisai and LONMIN PLC/S, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Eisai	0	0	2	0	3.00
LONMIN PLC/S	0	0	0	0	N/A

Insider & Institutional Ownership

0.0% of Eisai shares are held by institutional investors. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Profitability

This table compares Eisai and LONMIN PLC/S’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Eisai	4.11%	3.86%	2.50%
LONMIN PLC/S	N/A	N/A	N/A

Summary

Eisai beats LONMIN PLC/S on 8 of the 9 factors compared between the two stocks.

About Eisai

Eisai Co., Ltd. engages in the development, manufacture, and sale of prescription medicines and over-the-counter products. It operates through the Pharmaceutical Products Business and Other Business segments. The Pharmaceutical Products Business segment handles prescription and generic drugs, diagnostics, and consumer healthcare business in Japan, which manages over-the-counter drugs. The Other Business segment deals with food additives and chemicals. The company was founded by Toyoji Naito in November 1936 and is headquartered in Tokyo, Japan.

About LONMIN PLC/S

Lonmin Plc explores, mines, refines, and markets platinum group metals in South Africa, the Americas, Asia, and Europe. The company explores for platinum, palladium, rhodium, iridium, ruthenium, and gold, as well as chrome, nickel, copper, and cobalt deposits. Its flagship property is the Marikana mine located on the Western Limb of the Bushveld igneous complex in South Africa. In addition, the company holds 100% interest in Pandora mine. The company was founded in 1909 and is headquartered in Melrose North, South Africa.